Overview
Dr. Studzinski has over 50 years of experience in cancer research. In the last 30
years, he has focused on the anti-neoplastic effects of Vitamin D. In studies mostly
supported by the National Cancer Institute, the laboratory has advanced the
understanding of the signaling of differentiation, and thus normalization of the
malignant behavior of human Acute Myeloid Leukemia cells. Major findings included the
role of cell cycle inhibitor p27Kip1 in differentiation-related growth arrest, and
the participation of the MAPK signaling pathway in differentiation and cell death by
apoptosis induced by vitamin D analogs (VDAs). Current studies are translational,
with plans for a clinical trial of VDAs in AML.
Education
PHD, 1962, University of Glasgow
M.D., 1958, University of Glasgow
Licensure & Certification
Medical LicensureNew Jersey
Curriculum Vitae
View CVLanguages
Polish
